CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Osteoporosis - preventing steroid-induced - How up-to-date is this topic?
Changes
Version 1.3, revision planned in 2013.
Last revised in June 2009
November 2010 — minor update. Advice from the Medicines and Healthcare products Regulatory Agency (MHRA) that there is insufficient evidence to confirm a link between long-term use of oral bisphosphonates and oesophageal cancer has been added [MHRA, 2010]. Issued in November 2010.
October 2009 — minor update. Additional advice from the European Medicines Agency (EMEA) regarding osteonecrosis of the jaw associated with bisphosphonate treatment has been added [EMEA, 2009]. Issued in October 2009.
August 2009 — minor update. Prescriptions and prescribing information for bisphosphonates, and prescriptions for preparations containing calcium and vitamin D, are now included. Issued in August 2009.
December 2008 to June 2009 — this is a new CKS topic, based on the Royal College of Physicians guideline Glucocorticoid-induced osteoporosis [RCP, 2002].
© NHS Institute for Innovation and Improvement